Taking on New Challenges

Romark is developing innovative medications from a class of small molecule drugs called thiazolides.

Targeted therapeutic areas include viral diseases, cancers, pain, neurodegenerative diseases and aging-related diseases. We are presently conducting clinical trials of new drugs for treating illnesses caused by a broad range of viral respiratory infections and for treating chronic hepatitis B. Preclinical research is focused on new treatments for cancers, nerve pain and neurodegenerative diseases.